START ESMO IO Activity
2022 ESMO IMMUNO-ONCOLOGY (ESMO IO) ACTIVITY SUMMARY The START Center investigators contributed as authors to posters and abstracts at...
START ESMO IO Activity
START SITC Activity
2022 EORTC-NCI-AACR ACTIVITY SUMMARY
Exelixis Announces Initial Dose-Escalation Results from the First-in-Human Phase 1 Trial Evaluating
START Center for Cancer Care to Open New Locations in Lisbon and Dublin
Dr. Jay Messer Prostate Cancer Interview on kens5